Article
Tampa, Fla. — Although development of melanoma vaccines based on dendritic cells (DCs) lags behind that of more established approaches, it's rapidly moving from the lab bench into clinical trials.
FDA Clears Zabalafin Hydrogel’s Investigational New Drug Application for AD
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
At-Home Radiofrequency and Arbutin Cream Can Simultaneously Treat Melasma and Facial Aging
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Daily Derm Times: February 18, 2025
Aesthetic Treatments: More Than Just Enhancements, A Path to Empowerment